Cargando…

Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study

BACKGROUND: The effectiveness of ultrasound-based surveillance for HCC in patients with cirrhosis is limited by suboptimal sensitivity for early tumor detection and poor adherence. Emerging blood-based biomarkers have been proposed as an alternative surveillance strategy. We aimed to evaluate the co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chhatwal, Jagpreet, Samur, Sumeyye, Yang, Ju Dong, Roberts, Lewis R., Nguyen, Mindie H., Ozbay, A. Burak, Ayer, Turgay, Parikh, Neehar D., Singal, Amit G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538878/ https://www.ncbi.nlm.nih.gov/pubmed/37204402 http://dx.doi.org/10.1097/HC9.0000000000000146

Ejemplares similares

Comparison of a multitarget blood test to ultrasound and alpha‐fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta‐analysis
por: Singal, Amit G., et al.
Publicado: (2022)

Improved Health Outcomes from Hepatitis C Treatment Scale-Up in Spain’s Prisons: A Cost-Effectiveness Study
por: Dalgic, Ozden O., et al.
Publicado: (2019)

Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States
por: Nguyen, Mindie H., et al.
Publicado: (2022)

Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents
por: Chen, Qiushi, et al.
Publicado: (2020)

Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India
por: Aggarwal, Rakesh, et al.
Publicado: (2017)

Association of Limited In-Person Attendance in US National Football League and National Collegiate Athletic Association Games With County-Level COVID-19 Cases
por: Toumi, Asmae, et al.
Publicado: (2021)

Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan
por: Chhatwal, Jagpreet, et al.
Publicado: (2019)

Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic
por: Mehta, Neil, et al.
Publicado: (2021)

Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis
por: Klebanoff, Matthew J., et al.
Publicado: (2019)

Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study
por: Chen, Qiushi, et al.
Publicado: (2019)

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma
por: Parikh, Neehar D., et al.
Publicado: (2016)

Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis
por: Sonawane, Kalyani, et al.
Publicado: (2022)

Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis
por: Sonawane, Kalyani, et al.
Publicado: (2022)

Using cell-free DNA for HCC surveillance and prognosis
por: Tran, Nguyen H., et al.
Publicado: (2021)

Analysis of a Simulation Model to Estimate Long-term Outcomes in Patients with Nonalcoholic Fatty Liver Disease
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

Projecting COVID-19 Mortality as States Relax Nonpharmacologic Interventions
por: Linas, Benjamin P., et al.
Publicado: (2022)

Multidisciplinary care for patients with HCC: a systematic review and meta-analysis
por: Seif El Dahan, Karim, et al.
Publicado: (2023)

Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes
por: Ito, Takanori, et al.
Publicado: (2023)

A Real‐World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET‐HCC
por: Cabrera, Roniel, et al.
Publicado: (2020)

Discovery of Core-Fucosylated Glycopeptides as Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS
por: Tan, Yifei, et al.
Publicado: (2023)

Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort
por: Parikh, Neehar D., et al.
Publicado: (2022)

A Biomarker Panel Based upon AFP, Fucosylated Kininogen and PEG-Precipitated IgG Is Highly Accurate for the Early Detection Hepatocellular Carcinoma in Patients with Cirrhosis in Phase II and Phase III Biomarker Evaluation
por: Wang, Mengjun, et al.
Publicado: (2022)

When Can We Lift Non‐Pharmaceutical Interventions with the Availability of COVID‐19 Vaccine in the United States?
por: Chhatwal, Jagpreet, et al.
Publicado: (2021)

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
por: Lin, Yu, et al.
Publicado: (2022)

A Dual‐Filtration System for Single‐Cell Sequencing of Circulating Tumor Cells and Clusters in HCC
por: Chen, Vincent L., et al.
Publicado: (2022)

Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic
por: Chhatwal, Jagpreet, et al.
Publicado: (2021)

COVID-19 Health Economics: Looking Back and Scoping the Future
por: Postma, Maarten J., et al.
Publicado: (2022)

TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis
por: Brown, Andrew M., et al.
Publicado: (2022)

Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns
por: Soresi, Maurizio, et al.
Publicado: (2017)

How to improve HCC surveillance outcomes
por: Sherman, Morris
Publicado: (2019)

What Is the Optimal Threshold at Which to Recommend Breast Biopsy?
por: Burnside, Elizabeth S., et al.
Publicado: (2012)

HCC surveillance results in earlier HCC detection: results from an Indian cohort
por: Kohli, Anita, et al.
Publicado: (2014)

Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Parikh, Neehar D., et al.
Publicado: (2018)

A new proposal for secondary surveillance following potentially curative therapy of HCC: alternating MRI and CEUS
por: Bansal, Sanjay, et al.
Publicado: (2021)

Status of, and strategies for improving, adherence to HCC screening and surveillance
por: Francica, Giampiero, et al.
Publicado: (2019)

Should we undertake surveillance for HCC in patients with MAFLD?
por: Norero, Blanca, et al.
Publicado: (2023)

Alcohol-Associated Liver Disease Mortality Rates by Race Before and During the COVID-19 Pandemic in the US
por: Kulkarni, Neeti S., et al.
Publicado: (2023)

Advancing Age and Comorbidity in a US Insured Population‐Based Cohort of Patients With Chronic Hepatitis B
por: Nguyen, Mindie H., et al.
Publicado: (2019)

“Statistics 103” for Multitarget Tracking
por: Mahler, Ronald
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dhlgoqlf4128hue9pisce7r3rb